Eigentler, T.Heinzerling, L.Krauss, J.Weishaupt, C.Ochsenreither, S.Lebbe, C.Mohr, P.Oliva, M.Oberoi, H. K.Terheyden, P.Perez, J. M. TrigoRobert, C.Bauernfeind, F-G.Fluck, M.Richtig, E.Soria, A.Kays, S-K.Schmitt-Bormann, B.Falk, M.Gnad-Vogt, U. S.2025-01-072025-01-072021-09-210923-7534https://hdl.handle.net/10668/27062enIntratumorally administered CV8102 in patients with advanced solid tumors: Preliminary results from completed dose escalation in study 008conference outputopen access10.1016/j.annonc.2021.08.13941569-8041https://doi.org/10.1016/j.annonc.2021.08.1394700527702028